ZIM
TMO icon

Zacks Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

Zacks Investment Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20.8M Sell
42,404
-924
-2% -$501K 0.17% 129
2025
Q4 		$25.1M Sell
43,328
-323
-0.7% -$183K 0.2% 121
2025
Q3 		$21.2M Buy
43,651
+2,367
+6% +$1.1M 0.17% 133
2025
Q2 		$16.7M Sell
41,284
-151
-0.4% -$63.1K 0.14% 148
2025
Q1 		$20.6M Buy
41,435
+1,724
+4% +$934K 0.19% 129
2024
Q4 		$20.7M Sell
39,711
-6,022
-13% -$3.31M 0.19% 124
2024
Q3 		$28.3M Buy
45,733
+5,236
+13% +$3.1M 0.25% 108
2024
Q2 		$22.4M Buy
40,497
+3,937
+11% +$2.26M 0.25% 102
2024
Q1 		$21.2M Buy
36,560
+2,662
+8% +$1.49M 0.23% 107
2023
Q4 		$18M Buy
33,898
+142
+0.4% +$68.7K 0.22% 111
2023
Q3 		$17.1M Buy
33,756
+746
+2% +$398K 0.22% 110
2023
Q2 		$17.2M Buy
33,010
+942
+3% +$508K 0.22% 111
2023
Q1 		$18.5M Buy
32,068
+1,325
+4% +$747K 0.25% 101
2022
Q4 		$16.9M Buy
30,743
+92
+0.3% +$48.7K 0.24% 98
2022
Q3 		$15.5M Sell
30,651
-520
-2% -$291K 0.25% 95
2022
Q2 		$16.9M Buy
31,171
+1,511
+5% +$832K 0.26% 95
2022
Q1 		$17.5M Buy
29,660
+794
+3% +$456K 0.24% 97
2021
Q4 		$19.3M Buy
28,866
+757
+3% +$473K 0.27% 95
2021
Q3 		$16.1M Buy
28,109
+452
+2% +$248K 0.25% 98
2021
Q2 		$14M Sell
27,657
-6,918
-20% -$3.26M 0.23% 109
2021
Q1 		$15.8M Sell
34,575
-7,568
-18% -$3.61M 0.28% 97
2020
Q4 		$19.6M Buy
42,143
+34,372
+442% +$16.1M 0.36% 82
2020
Q3 		$3.43M Buy
+7,771
New +$3.21M 0.07% 169
2018
Q1 		– Sell
-25,525
Closed -$4.85M – 619
2017
Q4 		$4.85M Sell
25,525
-1,053
-4% -$202K 0.11% 151
2017
Q3 		$5.03M Sell
26,578
-410
-2% -$74.3K 0.12% 139
2017
Q2 		$4.71M Buy
+26,988
New +$4.53M 0.12% 143
2015
Q2 		– Sell
-1,838
Closed -$247K – 729
2015
Q1 		$247K Sell
1,838
-1,165
-39% -$150K 0.01% 553
2014
Q4 		$376K Buy
3,003
+17
+0.6% +$2.07K 0.01% 462
2014
Q3 		$363K Sell
2,986
-1,562
-34% -$190K 0.01% 466
2014
Q2 		$537K Buy
4,548
+524
+13% +$61.7K 0.02% 403
2014
Q1 		$484K Buy
4,024
+16
+0.4% +$1.9K 0.02% 405
2013
Q4 		$446K Sell
4,008
-630
-14% -$62.6K 0.02% 438
2013
Q3 		$427K Sell
4,638
-1,810
-28% -$164K 0.02% 394
2013
Q2 		$546K Buy
+6,448
New +$537K 0.03% 294

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Zacks Investment Management's TMO Position: Q1 2026 in Review

Zacks Investment Management reduced its Thermo Fisher Scientific (TMO) stake by 2.1% in Q1 2026, selling an estimated $501K and leaving 42,404 shares worth $20.8M. The position accounts for 0.17% of the portfolio, ranked #129.

Zacks Investment Management first reported a position in TMO in Q2 2013 and has held it in 34 quarters since. The position peaked at $28.3M in Q3 2024. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Zacks Investment Management held 42,404 shares of Thermo Fisher Scientific worth $20.8M as of Q1 2026.
  • Zacks Investment Management sold 924 Thermo Fisher Scientific shares in Q1 2026, an estimated $501K.
  • Thermo Fisher Scientific made up 0.17% of Zacks Investment Management's portfolio in Q1 2026, its #129 holding.
  • Zacks Investment Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 34 quarters since.
  • Zacks Investment Management's Thermo Fisher Scientific position peaked at $28.3M in Q3 2024.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Zacks Investment Management's 13F filing for Q1 2026, filed 14 May 2026.